Sara M Maffioletti
Overview
Explore the profile of Sara M Maffioletti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
135
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinton L, Khedr M, Lionello V, Sarcar S, Maffioletti S, Dastidar S, et al.
Nat Protoc
. 2023 Feb;
18(4):1337-1376.
PMID: 36792780
Skeletal muscle is a complex tissue composed of multinucleated myofibers responsible for force generation that are supported by multiple cell types. Many severe and lethal disorders affect skeletal muscle; therefore,...
2.
Jiang Y, Torun T, Maffioletti S, Serio A, Tedesco F
Exp Cell Res
. 2022 Apr;
416(2):113133.
PMID: 35427601
Engineering models of human skeletal muscle tissue provides unique translational opportunities to investigate and develop therapeutic strategies for acute muscle injuries, and to establish personalised and precision medicine platforms for...
3.
Steele-Stallard H, Pinton L, Sarcar S, Ozdemir T, Maffioletti S, Zammit P, et al.
Front Physiol
. 2018 Nov;
9:1332.
PMID: 30405424
Laminopathies are a clinically heterogeneous group of disorders caused by mutations in . The main proteins encoded by are Lamin A and C, which together with Lamin B1 and B2,...
4.
Maffioletti S, Gerli M, Ragazzi M, Dastidar S, Benedetti S, Loperfido M, et al.
Nat Protoc
. 2015 Aug;
10(9):1457.
PMID: 26313482
No abstract available.
5.
Maffioletti S, Gerli M, Ragazzi M, Dastidar S, Benedetti S, Loperfido M, et al.
Nat Protoc
. 2015 Jun;
10(7):941-58.
PMID: 26042384
Skeletal muscle is the most abundant human tissue; therefore, an unlimited availability of myogenic cells has applications in regenerative medicine and drug development. Here we detail a protocol to derive...
6.
Gerli M, Maffioletti S, Millet Q, Tedesco F
J Vis Exp
. 2014 Jan;
(83):e50532.
PMID: 24472871
Patient-derived iPSCs could be an invaluable source of cells for future autologous cell therapy protocols. iPSC-derived myogenic stem/progenitor cells similar to pericyte-derived mesoangioblasts (iPSC-derived mesoangioblast-like stem/progenitor cells: IDEMs) can be...